Get started

Gann

#TRAC: Unlocking Blockchain Supply ChainsDescription: This trading idea centers on TRAC, the native token of the OriginTrail ecosystem, a decentralized network that focuses on optimizing supply chains through blockchain technology. TRAC is designed to enhance transparency, data sharing, and interoperability across industries such as logistics, manufacturing, and retail. By leveraging decentralized protocols, OriginTrail provides verifiable data integrity and trust between different stakeholders, which can lead to more efficient and secure supply chain operations. As supply chain management continues to be a critical global issue, TRAC offers potential for growth, making it an attractive opportunity for investors seeking blockchain-driven solutions in this space. That said, it is important to understand that the cryptocurrency market remains highly volatile and can be influenced by regulatory changes, technological advancements, and broader market trends. Investing in TRAC carries inherent risks, and a cautious, informed approach is essential. Disclaimer: This trading idea is for educational purposes only and should not be considered financial advice. Cryptocurrencies, including TRAC, are speculative and carry a high level of risk, including the potential for total capital loss. Conduct your own thorough research, consider your financial situation, and consult with a professional advisor before making any investment decisions. Past performance is not indicative of future results.
Long
by MoonTradingForecast
A Glimpse into My 2025 Stock Picks (US Edition)As we enter 2025, the U.S. stock market presents a landscape ripe with opportunities. The Federal Reserve's recent meeting minutes indicate a cautious yet optimistic approach, suggesting that while inflationary pressures are being monitored, the overall economic outlook remains positive. This balanced stance bodes well for investors seeking growth in the coming year. Janux Therapeutics Inc. (NASDAQ: JANX) Janux Therapeutics is a clinical-stage biopharmaceutical company specializing in the development of novel immunotherapies for cancer treatment. Leveraging its proprietary Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, Janux aims to create therapies that are both effective and safe. In the third quarter of 2024, the company reported financial results highlighting its ongoing commitment to advancing its pipeline, with significant investments in research and development. LandBridge Company LLC (NYSE: LB) LandBridge is a landowner in the oil-rich Permian Basin, focusing on leasing its extensive acreage to oil and natural gas producers. Since its IPO in mid-2024, where shares debuted at $19 each, the company has demonstrated robust revenue growth. In the third quarter of 2024, LandBridge reported a 60% year-over-year increase in revenues, reaching $28.5 million. This growth underscores the company's strategic positioning and the strong demand for its assets. Ryde Group Limited (NYSE: RYDE) Ryde Group is a transportation and mobility services provider, offering a range of solutions from ride-sharing to electric scooter rentals. In Singapore, the recent surge in Certificate of Entitlement (COE) prices has significantly increased the cost of car ownership, pushing consumers toward more affordable e-mobility options. Ryde, as a niche player in this industry, stands to benefit from this shift. Additionally, the company's current low valuation provides a safety net for investors, making it an attractive prospect in the evolving mobility landscape. In conclusion, the U.S. stock market in 2025 appears poised for continued growth, supported by a stable economic environment and strategic corporate advancements. Investors should consider companies like Janux Therapeutics, LandBridge Company, and Ryde Group, each offering unique value propositions in their respective sectors. Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investors should conduct their own research or consult with a financial advisor before making investment decisions.
AMEX:RYDELong
by HASHInvests200
Gold encounters safe-haven rally, trend analysis and strategyLast week, the daily gold line fell to 2536 and supported on the 20-day moving average. Affected by the risk aversion of Russia and Ukraine at the end of the week, the Asian session rose by $30 compared with last Friday, and the price was above the oscillating platform. From the perspective of the 1-hour chart, the rebound has not ended! Sell high and buy low during the day! The 4-hour moving average of gold is still arranged in a bearish divergent downward, and there is still no sign of turning. The decline of gold has not ended. In the short term, it is just a rebound. There are still many resistances above gold. Continue to go short at highs under the upper resistance of 2618. Gold 2616 can enter the market first. First support: 2571, second support: 2563, third support: 2554 First resistance: 2605, second resistance: 2616, third resistance: 2627 Trading strategy: BUY:2573-2571 SELL:2616-2618 Sell high and buy low according to resistance support
OANDA:XAUUSDShort
by Jun-GoldAnalyst
ChainLink (LINK/USDT)The chart for ChainLink (LINK/USDT) suggests a breakout from a descending wedge pattern, signaling bullish potential. Key Levels: Support Zone: $12.87–$13.50 (retest area). Stop Loss: Below $8.70 to manage risk. Target 1 (T1): $20.02 Target 2 (T2): $26.21 Target 3 (T3): $32.40 Recommendations: Entry Point: Consider buying on a retest near $12.87 if support holds. Risk Management: Place a stop-loss below $8.70. Outlook: A confirmed breakout and volume increase could drive prices to higher targets, with $32.40 as the long-term goal.
Long
by VIPROSE
2